Top Markets
Coin of the day
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Rank in Stocks #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Share Price
$0.10205262
Last synced: 2026-04-23
Market Cap
$1.32M
Change (1 day)
5.19%
Change (1 year)
-54.38%
Country
GB
Trade Roquefort Therapeutics plc (ROQ)

Category

Dividend yield history for Roquefort Therapeutics plc (ROQ)
Roquefort Therapeutics plc (stock symbol: ROQ) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Roquefort Therapeutics plc (ROQ) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors